Kriti Nutrients announces 30th AGM on August 12, 2026, to approve FY26 financials and interim dividend.
Kriti Nutrients Limited will hold its 30th AGM on August 12, 2026, via VC/OAVM. The meeting will approve FY26 financial statements and confirm an interim dividend of ₹3.00 per share paid on November 8, 2025. The agenda also includes re-appointments of directors and auditors.
The AGM is a significant corporate event where key decisions are made regarding financial statements, dividends, and leadership appointments. While routine, these decisions can have a medium-term impact on governance and shareholder value.
The announcement is a routine notice for the Annual General Meeting and does not contain any new financial performance data or strategic changes that would significantly impact the company's outlook. It is a procedural event.
Kriti Nutrients Limited has announced the 30th Annual General Meeting (AGM) to be held on Wednesday, August 12, 2026, at 4:30 PM IST. The meeting will be conducted through Video Conferencing (VC) or Other Audio Video Means (OAVM), with the corporate office in Indore deemed as the venue. The AGM will consider and adopt the audited standalone and consolidated financial statements for the Financial Year ended March 31, 2026.
Key agenda items include confirming the interim dividend of ₹3.00 per equity share (300%) declared on November 8, 2025, amounting to ₹1503.11 Lakhs for FY 2025-26. The meeting will also address the re-appointment of Mr. Saurabh Singh Mehta as a Director retiring by rotation, the re-appointment of M/s M Mehta & Company as Statutory Auditors for a five-year term until the 35th AGM in 2031, and ratification of the Cost Auditor's remuneration for FY 2026-27.
Furthermore, the AGM will seek member approval for the revision in remuneration for Mr. Saurabh Singh Mehta as Whole-time Director and Joint Managing Director, and the re-appointment and fixation of remuneration for Mr. Shiv Singh Mehta as Chairman and Managing Director for a further term of three years.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.